Pfizer CEO Albert Bourla told CBS News' "Face the Nation" Sunday that his company will know whether its coronavirus vaccine is effective by the end of October and that it has already manufactured hundreds of thousands of doses in anticipation that the vaccine will receive FDA approval.
Why it matters: There has been a major push by the Trump administration to get a coronavirus vaccine to the public this fall, though it may only be available for certain high-risk groups. The Centers for Disease Control and Prevention has already urged governors to have vaccine distribution centers ready by November.
Yes, but: 62% of adults say they're worried the FDA will rush to approve a vaccine under political pressure from President Trump, according to a poll by the Kaiser Family Foundation.
- Politico reported on Friday that Trump-appointed health department aides interfered with the CDC’s weekly COVID-19 reports “in what officials characterized as an attempt to intimidate the reports’ authors and water down their communications to health professionals."
- Only 14% of Americans think a coronavirus vaccine will be widely available before the November election, and even if it is, most Americans say they won't take it.
